A viral ER-resident glycoprotein inactivates the MHC-endoced peptide transporter

Immunity

Volumn 6, Issue 5, 1997, Pages 623-632

  Hengel, Hartmut ^a   Koopmann, Jens Oliver ^b   Flohr, Thomas ^a   Muranyi, Walter ^a   Goulmy, Els ^c   Hämmerling, Günter J ^b   Koszinowski, Ulrich H ^a   Momburg, Frank ^b  

^a UNIVERSITY OF MUNICH   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; CALNEXIN; CALRETICULIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; TAPASIN; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN;

ARTICLE; CELL LINE; ENDOPLASMIC RETICULUM; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; IMMUNOREGULATION; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL;

EID: 0030978748     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80350-7     Document Type: Article

References (62)

1. Ahn, K., Angulo, A., Ghazal, P., Peterson, P.A., Yang, Y., and Früh, K. (1996). Human cytomegalovirus inhibits antigen presentation by a sequential multistep process. Proc. Natl. Acad. Sci. USA 93, 10990-10995.
2. Ahn, K., Meyer, T.H., Uebel, S., Sempé, P., Djaballah, H., Yang, Y., Peterson, P.A., Früh, K., and Tampé, R. (1996). Molecular mechanism and species specificity of TAP inhibition by herpes simplex virus protein ICP47. EMBO J. 15, 3247-3255.
3. Androlewicz, M.J., Anderson, K.S., and Cresswell, P. (1993). Evidence that transporters associated with antigen processing translocate a major histocompatibility complex class I-binding peptide into the endoplasmic reticulum in an ATP-dependent manner. Proc. Natl. Acad. Sci. USA 90, 9130-9134.
4. Androlewicz, M.J., Ortmann, B., van Endert, P.M., Spies, T., and Cresswell, P. (1994). Characteristics of peptide and major histocompatibility complex class I/β2-microglobulin binding to the transporters associated with antigen processing (TAP1 and TAP2). Proc. Natl. Acad. Sci. 91, 12176-12720.
5. Androlewicz, M.J., and Cresswell, P. (1996). How selective is the transporter associated with antigen processing? Immunity 5, 1-5.
6. Barnes, P.D., and Grundy, J.E. (1992). Down-regulation of the class HLA heterodimer and β2-microglobulin on the surface of cells infected with cytomegalovirus. J. Gen. Virol. 73, 2395-2403.
7. Beersma, M.F.C., Bijlmakers, M.J.E., and Ploegh, H.L. (1993). Human cytomegalovirus down-regulates HLA class I expression by reducing the stability of class I H chains. J. Immunol. 151, 4455-4464.
8. Borysiewicz, L.K., Hickling, J.K., Graham, S., Sinclair, J., Cranage, M.P., Smith, G.L., and Sissons, J.G.P. (1988). Human cytomegalovirus-specific cytotoxic T cells. Relative frequency of stage-specific CTL recognising the 72-kD immediate early protein and glycoprotein B expressed by recombinant vaccinia viruses. J. Exp. Med. 168, 919-931.
9. Degen, E., and Williams, D.B. (1991). Participation of a novel 88-kD protein in the biogenesis of murine class I histocompatibility molecules. J. Cell. Biol. 112, 1099-1115.
10. Del Val, M., Hengel, H., Häcker, H., Hartlaub, U., Ruppert, T., Lucin, P., and Koszinowski, U.H. (1992). Cytomegalovirus prevents antigen presentation by blocking the transport of peptide-loaded major histocompatibility complex class I molecules into the medial-Golgi compartment. J. Exp. Med. 172, 729-738.
11. DeMars, R., Rudersdorf, R., Chang, C., Petersen, J., Strandtmann, J., Korn, N., Sidwell, B., and Orr, H.T. (1985). Mutations that impair a post-transcriptional step in expression of HLA-A and -B antigens. Proc. Natl. Acad. Sci. USA 82, 8183-8187.
12. Früh, K., Ahn, K., Djaballah, H., Sampe, P., van Endert, P.M., Tampe, R., Peterson, P.A., and Yang, Y. (1995). A viral inhibitor of peptide transporters for antigen presentation. Nature 375, 415-418.
13. Goulmy, E., van der Poel, J., Giphart, M., and van Rood, J.J. (1984). Analysis of functional epitopes on different HLA-A2 molecules. Immunogenetics 20, 13-21.
14. Grandea, A.G. III, Androlewicz, M.J., Athwal, R.S., Geraghty, D.E., and Spies, T. (1995). Dependence of peptide binding by MHC class I molecules on their interaction with TAP. Science 270, 105-108.
15. Greenwood, R., Shimizu, Y., Sedhon, G.S., and DeMars, R. (1994). Novel allele-specific, post-translational reduction in HLA class I surface expression in a mutant B cell line. J. Immunol. 153, 5525-5536.
16. Heemels, M.T., and Ploegh, H.L. (1995). Generation, translocation, and presentation of MHC class I-restricted peptides. Annu. Rev. Biochem. 64, 463-491.
17. Hengel, H., Lucin, P., Jonjic, S., Ruppert, T., and Koszinowski, U.H. (1994). Restoration of cytomegalovirus antigen presentation by gamma interferon combats viral escape. J. Virol. 68, 289-297.
18. Hengel, H., Eßlinger, C., Pool, J., Goulmy, E., and Koszinowski, U.H. (1995). Cytokines restore MHC class I complex formation and control antigen presentation in human cytomegalovirus-infected cells. J. Gen. Virol. 76, 2987-2997.
19. Hengel, H., Flohr, T., Hämmerling, G.J., Koszinowski, U.H., and Momburg, F. (1996). Human cytomegalovirus inhibits peptide translocation into the endoplasmic reticulum for MHC class I assembly. J. Gen. Virol. 77, 2287-2296.
20. Hill, A., Jugovic, P., York, I., Russ, G., Bennink, J., Yewdell, J., Ploegh, H., and Johnson, D. (1995). Herpes simplex virus turns off the TAP to evade host immunity. Nature 375, 411-415.
21. Ho, M. (1982). Human cytomegalovirus infections in immunosuppressed patients. In Cytomegalovirus Biology and Infection: Current Topics in Infectious Disease, W.B. Greenough and T.C. Merrigan, eds. (New York: Plenum Press), pp. 171-204.
22. Hopkins, J.I., Fiander, A.N., Evans, A.S., Delchambre, M., Gheysen, D., and Borysiewicz, L.K. (1996). Cytotoxic T cell immunity to human cytomegalovirus glycoprotein B. J. Med. Virol. 49, 124-131.
23. Jackson, M.R., Nilsson, T., and Peterson, P.A. (1990). Identification of a consensus motif for retention of transmembrane proteins in the endoplasmic reticulum. EMBO J. 9, 3153-3162.
24. Jones, T.R., and Muzithras, V.P. (1991). Fine mapping of transcripts expressed from the US6 gene family of human cytomegaolvirus strain AD169. J. Virol. 65, 2024-2036.
25. Jones, T.R., Hanson, L.K., Sun, L., Slater, J.S., Stenberg, R.S., and Campbell, A.E. (1995). Multiple independent loci within the human cytomegalovirus unique short region down-regulate expression of major histocompatibility complex class I heavy chains. J. Virol. 69, 4830-4841.
26. Jones, T.R., Wiertz, E.J.H.J., Sun, L., Fish, K.N., Nelson, J.A., and Ploegh, H.L. (1996). Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains. Proc. Natl. Acad. Sci. USA 93, 11327-11333.
27. Kleijmeer, M., Kelly, A., Geuze, H.J., Slot, J.W., Townsend, A., and Trowsdale, J. (1992). Location of MHC-encoded transporters in the endoplasmic reticulum and cis-Golgi. Nature 357, 342-344.
28. Kleijnen, M., Huppa, J.B., Lucin, P., Mukherjee, S., Farrell, H., Campbell, A., Koszinowski, U.H., Hill, A.B., and Ploegh, H.L. (1997). A mouse cytomegalovirus glycoprotein, gp34, forms a complex with folded class I MHC molecules in the ER which is not retained but transported to the cell surface. EMBO J. 16, 685-694.
29. Koopmann, J.-O., Hämmerling, G.J., and Momburg, F. (1997).Generation, intracellular transport and loading of peptides associated with MHC class I molecules. Curr. Opin. Immunol. 9, 80-88.
30. Momburg, F., Neefjes, J.J., and Hämmerling, G.J. (1994a). Peptide selection by MHC-encoded TAP transporters. Curr. Opin. Immunol. 6, 32-37.
31. Momburg, F., Roelse, J., Hämmerling, G.J., and Neefjes, J.J. (1994b). Peptide size selection by the major histocompatibility complex-encoded peptide transporter. J. Exp. Med. 179, 1613-1623.
32. Neefjes, J.J., Momburg, F., and Hämmerling, G.H. (1993). Selective and ATP-dependent translocation of peptides by the MHC-encoded transporter. Science 261, 769-771.
33. Nijenhuis, M., Schmitt, S., Armandola, E.A., Obst, R., Brunner, J., and Hämmerling, G.J. (1996). Identification of a contact region for peptide on the TAP1 chain of transporter associated with antigen presentation. J. Immunol. 156, 2186-2195.
34. Ortmann, B., Androlewicz, M., and Cresswell, P. (1994). MHC class I/β2-microglobulin complexes associate with TAP transporters before peptide binding. Nature 368, 864-867.
35. Ou, W.-J., Cameron, P.H., Thomas, D.Y., and Bergeron, J.J.M. (1993). Association of folding intermediates of glycoproteins with calnexin during protein maturation. Nature 364, 771-776.
36. Palmer, D.J., Helms, J.B., Beckers, C.J., Orci, L., and Rothman, J.E. (1993). Binding of coatomer to Golgi membranes requires ADP-ribosylation factor. J. Biol. Chem. 268, 12083-12089.
37. Parham, P., Barnstable, C.J., and Bodmer, W.F. (1979). Use of monoclonal antibody (w6/32) in structural studies of HLA-A, B, Cantigens. J. Immunol. 123, 342-349.
38. Rajagopalan, S., and Brenner, M.B. (1994). Calnexin retains unassembled major histocompatibility complex class I free heavy chains in the endoplasmic reticulum. J. Exp. Med. 180, 407-412.
39. Russ, G., Esquivel, F., Yewdell, J.W., Cresswell, P., Spies, T., and Bennink, J.R. (1995). Assembly, intracellular localization, and nucleotide binding properties of the human peptide transporters TAP1 and TAP2 expressed by recombinant vaccinia virus. J. Biol. Chem. 270, 21312-21318.
40. Sadasivan, B., Lehner, P.J., Ortmann, B., Spies, T., and Cresswell, P. (1996). Roles for calreticulin and a novel glycoprotein, tapasin, in the interaction of MHC class I molecules with TAP. Immunity 5, 103-114.
41. Scheele, G. (1983). Methods for the study of protein translocation across the RER membrane using the reticulocyte lysate system and canine pancreatic microsomal membranes. Meth. Enzymol. 96, 94-111.
42. Schlicht, H.-J., and Schaller, H. (1989). The secretory core protein of human hepatitis B virus is expressed on the cell surface. J. Virol. 63, 5399-5404.
43. Schweizer, A., Fransen, J.A.M., Matter, K., Kreis, T.E., Ginsel, L., and Hauri, H.-P. (1990). Identification of an intermediate compartment involved in protein transport from endoplasmic reticulum to Golgi apparatus. Eur. J. Cell Biol. 53, 185-196.
44. Shepherd, J.C., Schumacher, T.N.M., Ashton-Rickardt, P.G., Imaeda, S., Ploegh, H.L., Janeway, C.A., and Tonegawa, S. (1993). TAP1-dependent peptide translocation in vitro is ATP dependent and peptide selectice. Cell 74, 577-584.
45. Solheim, J.C., Harris, M.R., Kindle, C.S., and Hansen, T.H. (1997). Prominence of β2-microglobulin, class I heavy chain conformation, and tapasin in the interactions of class I heavy chain with calreticulin and the transporter associated with antigen processing. J. Immunol. 158, 2236-2241.
46. Stam, N.J., Spits, H., and Ploegh, H.L. (1986). Monoclonal antibodies raised against denatured HLA-B locus H-chains permit biochemical characterization of certain HLA-C locus products. J. Immunol. 137, 2299-2306.
47. Suh, W.-K., Cohen-Doyle, M.F., Fruh, K., Wang, K., Peterson, P.A., and Williams, D.B. (1994). Interaction of MHC class I molecules with the transporter associated with antigen processing. Science 264, 1322-1326.
48. Suh, W.-K., Mitchell, E.K., Young, Y., Peterson, P.A., Wanek, G., and Wiliams, D.B. (1996). MHC class I molecules form ternary complexes with calnexin and TAP and undergo peptide-regulated interaction with TAP via their extracellular domains. J. Exp. Med. 184, 337-348.
49. Tenney, D.J., and Colberg-Poley, A.M. (1991). Human cytomegalovirus UL36-38 and US3 immediate-early genes: temorally regulated expression of nuclear, cytoplasmic, and polysome-associated transcripts during infection. J. Virol. 65, 6724-6734.
50. Thäle, R., Szepan, U., Hengel, H., Geginat, G., Lucin, P., and Koszinowski, U.H. (1995). Identification of the mouse cytomegalovirus genomic region affecting major histocompatibility complex class I molecule transport. J. Virol. 69, 6098-6105.
51. Tomazin, R., Hill, A.B., Jugovic, P., York, I., van Endert, P., Ploegh, H.L., Andrews, D.W., and Johnson, D.C. (1996). Stable binding of the herpes simplex virus ICP47 protein to the peptide binding site of TAP. EMBO J. 15, 3256-3266.
52. Townsend, A., Elliot, T., Cerundolo, V., Foster, L., Barber, B., and Tse, A. (1990). Assembly of MHC class I molecules analyzed in vitro. Cell 62, 285-295.
53. van Endert, R., Tampe, R., Meyer, T.H., Tisch, R., Bach, J.-F., and McDevitt, H.O. (1994). A sequential model for peptide binding and transport by the transporters associated with antigen processing. Immunity 1, 491-500.
54. Vaux, D., Tooze, J., and Fuller, S. (1990). Identification by anti-idiotype antibodies of an intracellular membrane protein that recognizes a mammalian endoplasmic reticulum retention signal. Nature 345, 495-502.
55. Volkmer, H., Bertholet, C., Jonjic, S., Wittek, R., and Koszinowski, U.H. (1987). Cytolytic T lymphocyte recognition of the mouse cytomegalovirus nonstructural immediate-early protein pp89 expressed by recombinant vaccinia virus. J. Exp. Med. 166, 668-677.
56. Warren, A.P., Ducroq, D.H., Lehner, P.J., and Borysiewicz, L.K. (1994). Human-cytomegalovirus-infected cells have unstable assembly of major histocompatibility complex class I complexes and are resistant to lysis by cytotoxic T lymphocytes. J. Virol. 68, 2822-2829.
57. Wiertz, E.J.H.J., Jones, T.R., Sun, L., Bogyo, M., Geuze, H.J., and Ploegh, H.L. (1996a). The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell 84, 769-779.
58. Wiertz, E.J.H.J., Tortorella, D., Bogyo, M., Yu, J., Mothes, W., Jones, T.R., Rapoport, T.A., and Ploegh, H.L. (1996b). Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasomefor destruction. Nature 384, 432-438.
59. Yamashita, Y., Shimokata, K., Mizuno, S., Yamaguchi, H., and Nishiyama, Y. (1993). Down-regulation of the surface expression of class I MHC antigens by human cytomegalovirus. Virology 193, 727-736.
60. Yewdell, J.W., and Bennink, J.R. (1992). Cell biology of antigen processing and presentation to MHC class I molecule-restricted T lymphocytes. Adv. Immunol. 52, 1-123.
61. York, I. (1996). Immune evasion strategies of the herpesviruses. Chem. Biol. 3, 331-335.
62. Ziegler, H., Thäle, R., Lucin, P., Muranyi, W., Flohr, T., Hengel, H., Farell, H., Rawlinson, W., and Koszinowski, U.H. (1997). A mouse cytomegalovirus glycoprotein retains MHC class I complexes in the ERGIC/cis-Golgi. Immunity 6, 57-66.